Upstream Bio, Inc. (UPB) Financials

UPB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 281.2 million 10.2 million
March 31, 2026 318.1 million 14.1 million
Dec. 31, 2025 353.8 million 14.0 million
Sept. 30, 2025 391.2 million 12.6 million

UPB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -35.6 million 4.4 million
March 31, 2026 -47.9 million 4.6 million
Dec. 31, 2025 -30.7 million 2.5 million
Sept. 30, 2025 -22.2 million 2.6 million

UPB Net Income

No data available :(

UPB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 261.3 million 226000 -
March 31, 2026 294.6 million 390000 -
Dec. 31, 2025 341.5 million 549000 -
Sept. 30, 2025 372.4 million 703000 -

UPB Shares Outstanding

No data available :(

UPB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 36.1 million 7.1 million -
March 31, 2026 - 36.6 million 8.1 million -
Dec. 31, 2025 47000 40.2 million 6.7 million -
Sept. 30, 2025 47000 33.0 million 5.5 million -

UPB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 773000 -
March 31, 2026 1.0 million 49000
Dec. 31, 2025 668000 57000
Sept. 30, 2025 683000 31000

UPB

Price: $6.85

52 week price:
5.85
33.68

Earnings Per Share: -6.31 USD

P/E Ratio: -1.22

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 373.9 million

Links: